IBIO-610 combined with semaglutide targets fat loss while protecting muscle
IBio’s eight-week obese nonhuman primate study (n=6 per group) found lean mass comprised 6% of weight lost with IBIO-610 plus semaglutide versus 22% with semaglutide alone. The company claims additional analysis showed fat accounted for 93% of weight loss with a single dose of IBIO-610 plus tw
<p>IBio’s eight-week obese nonhuman primate study (n=6 per group) found lean mass comprised 6% of weight lost with IBIO-610 plus semaglutide versus 22% with semaglutide alone. The company claims additional analysis showed fat accounted for 93% of weight loss with a single dose of IBIO-610 plus tw</p>